Brief: Emmaus Life Sciences Details Financial Benefits From Recent Merger

Emmaus Life Sciences

29/07/2019 13:06

July 29 (Reuters) - Emmaus Life Sciences Inc  EMMA.O :
    * EMMAUS LIFE SCIENCES DETAILS FINANCIAL BENEFITS FROM
RECENT
MERGER, INCLUDING IMPROVED BALANCE SHEET AND REDUCED DEBT
SERVICE
    * EMMAUS LIFE SCIENCES INC - COMPANY TO APPEAL NASDAQ
STAFF'S
DETERMINATION
    * EMMAUS LIFE SCIENCES - PRIOR TO MERGER, ABOUT $35.5
MILLION
CONVERTIBLE PROMISSORY NOTES, NOTES PAYABLE OF UNIT CONVERTED
INTO SHARES OF EMI COMMON STOCK
    * EMMAUS LIFE SCIENCES INC - STOCK WILL CONTINUE TO TRADE ON
NASDAQ CAPITAL MARKET UNTIL HEARING, WHICH IS SCHEDULED FOR
SEPTEMBER 5
    * EMMAUS LIFE SCIENCES INC - CONVERSION OF NOTES EXPECTED TO
SAVE
EMMAUS ABOUT $3.6 MILLION IN ANNUAL INTEREST EXPENSE

Source text for Eikon:  ID:nPn3sqSJZa 
Further company coverage:  EMMA.O 

 ((Reuters.Briefs@thomsonreuters.com;))